A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs
Emerging Oseltamivir-resistant influenza strains pose a critical public health threat due to antigenic shifts and drifts. We report an innovative strategy for controlling influenza A infections by use of a novel minibody of the 3D8 single chain variable fragment (scFv) showing intrinsic viral RNA hy...
Main Authors: | Yongjun Lee, Phuong Thi Hoang, Dongjun Kim, Ramadhani Qurrota Ayun, Quynh Xuan Thi Luong, Kyungho Na, Taehyun Kim, Yeonsu Oh, Won-Keun Kim, Sukchan Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/5/1105 |
Similar Items
-
A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain VL and an RNA hydrolyzing scFv
by: Phuong Thi Hoang, et al.
Published: (2024-04-01) -
A Novel Approach of Antiviral Drugs Targeting Viral Genomes
by: Phuong Thi Hoang, et al.
Published: (2022-07-01) -
Headlines for Health! The Lead Scenario
by: Joy C. Jordan, et al.
Published: (2007-08-01) -
An RNA-hydrolyzing recombinant minibody prevents both influenza A virus and coronavirus in co-infection models
by: Quynh Xuan Thi Luong, et al.
Published: (2024-04-01) -
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells
by: Daniel V. Kalinovsky, et al.
Published: (2023-01-01)